LAWRENCE, Mass., June 9, 2006 /PRNewswire-FirstCall/ -- NxStage Medical, Inc. (Nasdaq: NXTM - News), the manufacturer of the NxStage System One(TM) portable kidney dialysis machine, announced the offering of 5,613,371 shares of its common stock at a price to the public of $8.75 per share. Of the 5,613,371 shares, 5,500,000 shares are being sold by NxStage for expected total net proceeds of approximately $44.6 million to NxStage, after deducting underwriting discounts and commissions and estimated offering expenses, and 113,371 shares are being sold by selling stockholders. NxStage will not receive any proceeds from the sale of shares by the selling stockholders.
